Alfonso Illiano
University of Naples Federico II · 17 works · 6,631 citations · h-index 13
Top works
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- Gemcitabine Plus Vinorelbine Compared With Cisplatin Plus Vinorelbine or Cisplatin Plus Gemcitabine for Advanced Non–Small-Cell Lung Cancer: A Phase III Trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group
- Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials
- Phase I-II Study of Gemcitabine and Carboplatin in Stage IIIB-IV Non–Small-Cell Lung Cancer
- Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer
- Cisplatin Plus Gemcitabine or Vinorelbine for Elderly Patients With Advanced Non–Small-Cell Lung Cancer: The MILES-2P Studies
- EGFR and KRAS mutations detection on lung cancer liquid-based cytology: a pilot study
- EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non–small cell lung carcinoma patients
- Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations
- EGFR mutations detection on liquid-based cytology: is microscopy still necessary?
- Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with nivolumab: The Italian NSCLC expanded access program
- Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials
- Phase I–II study of gemcitabine and paclitaxel in pretreated patients with stage IIIB–IV non-small cell lung cancer
- Phase I study of vinorelbine and paclitaxel in small-cell lung cancer
- Phase I/II study of gemcitabine and epirubicine in stage IIIB-IV non small cell lung cancer
- P3.02c-092 Nivolumab in Multi-Treated Patients with Advanced Sq-NSCLC: Data from the Italian Cohort of Expanded Access Programme (EAP)